News Scan for Jan 08, 2018

Saudi MERS cases
;
Next-gen flu vaccine grant
;
New H5N6 infection
;
Yellow fever in Nigeria
;
Salmonella in Europe

Saudi Arabia identifies 2 new MERS cases

The Saudi Arabian Ministry of Health (MOH) recorded two new cases of MERS-CoV in Riyadh in recent days.

On Jan 5, a 48-year-old Saudi man from the country's capital was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus) after presenting with symptoms. He is in stable condition. The MOH said the man had direct contact with camels, a known risk factor for MERS-CoV.

Yesterday, another Saudi man from Riyadh was diagnosed as having the disease. The 36-year-old is in critical condition. The source of his infection is listed as "primary," meaning it's unlikely he contracted the virus from another person.

On Jan 6 the MOH also reported the death of a patient who was diagnosed last week, a 55-year-old male expatriate from Khamis Mushait. He was not a healthcare worker and had preexisting disease.

Saudi Arabia's MERS-CoV case count since 2012 has now reached 1,765, including 715 deaths. Six patients are still being treated, according to the MOH.
Jan 5 MOH report
Jan 6 MOH report
Jan 7 MOH report

 

Sabin announces $6.6 million grant for next-generation flu vaccines

The Sabin Vaccine Institute today announced a new 3-year $6.6 million grant—supported by the Page Family Donor Advised Fund—to speed the development of next-generation flu vaccines. Also, the funding is designed to support immunization-related issues, Sabin, a nonprofit global health group based in Washington, DC, said in its press release today.

Bruce Gellin, MD, MPH, Sabin's president of global immunization, said this year marks the 100th anniversary of the 1918 Spanish flu pandemic, and the world must not wait any longer to develop new vaccines with the potential to eliminate the threat of pandemic and seasonal flu. "Promising research is already underway, but we know we need to do more to ensure that a so-called 'universal flu vaccine' is available before we need it," he said in the statement.

As part of the plans to boost flu vaccine research, Sabin said it will establish an Influenza Leadership Council to identify novel approaches and communicate the urgent need for next-generation vaccines. The members will support an influenza advocacy work to engage the public, such as workshops and pandemic flu simulations. The grant will also support a project with the Aspen Institute's Health, Medicine, and Society Program to establish a group to tackle vaccine science and policy strategy.

In 2012, an expert panel led by the University of Minnesota's Center for Infectious Disease Research and Policy (CIDRAP), the publisher of CIDRAP News, detailed protection gaps in current flu vaccines and problems with their production and urgently called for game-changing flu vaccines.
Jan 8 Sabin Vaccine Institute press release
2012 CIDRAP report

 

Chinese child recovers after H5N6 infection

China has reported another human H5N6 avian flu case, which involved a 3-year-old girl from Fujian province who had contact with live poultry before she became ill, Hong Kong's Centre for Health Protection (CHP) said in a Jan 6 statement.

The girl recovered after treatment, and so far her close contacts have not reported any symptoms. Her illness marks China's 18th involving H5N6 since the first human case was detected in 2014. At least 10 of the patients died from their infections. She is the second child to be affected by the virus.

China reported its last H5N6 case in November, involving a 33-year-old man from Guangxi province who also had contact with live poultry before he became ill.
Jan 6 CHP statement

 

Number of confirmed yellow fever cases in Nigeria grows to 33

A World Health Organization (WHO) lab has confirmed a new yellow fever case in Nigeria, while the number of total cases in the country has climbed to 358, Nigeria's Centre for Disease Control (NCDC) reported in an update posted late last week.

As of Jan 2, 33 of 63 samples that had initially tested positive in Nigerian labs were confirmed as positive for yellow fever at a WHO reference lab in Dakar, Sengal. That is one more confirmed case than the WHO reported on Dec 22. Since the Dec 22 WHO update, the NCDC has reported 17 new confirmed and suspected cases, for a total of 358.

The new confirmed case was in Niger state, which brings the number of states with confirmed cases to seven, one more than the WHO had reported. Sixteen states have reported suspected cases.

About 68% of patients are 20 years and younger, and 62% are male. The outbreak started in Kwara state in September 2017.
Jan 5 NCDC update
Dec 27
CIDRAP news scan on WHO update

 

European salmonellosis outbreak tied to infant formula grows

An outbreak of Salmonella Agona infections in European infants has grown by 1 case, to 36 infections, with an additional case possible, the European Centre for Disease Prevention and Control (ECDC) said in a Jan 5 update.

The WHO first announced the outbreak on Dec 22, when 25 infants in France were known to be infected. Since then Spanish health officials have confirmed a case in an infant, and Greece might also have a case, the ECDC said. Different brands of infant formula from the same producer in France—Lactalis Nutrition Sante—have been implicated. The formula was distributed to 48 countries, including some in Africa, Asia, the Middle East, and French overseas territories, the WHO noted.

"The Institut Pasteur in Paris reported that S. Agona isolates associated with the outbreak displayed an atypical characteristic allowing the identification of cases probably associated with the outbreak," the ECDC said in its update. It added, "A joint whole genome sequencing (WGS) analysis confirmed that the Spanish case is associated with the ongoing outbreak in France and may provide further confirmation whether also the Greek case and possible cases from other countries are associated."

A broad recall of the products was initiated last month.
Jan 5 ECDC update
Dec 22
CIDRAP News scan on WHO statement

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»